Vimarsana
Biggest News Aggregation in the World

Package Level News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Package Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Package Level Today - Breaking & Trending Today

U.S.: FDA enforcement of certain DSCSA requirements delayed until November 2024 | Hogan Lovells - Vimarsana News

U.S.: FDA enforcement of certain DSCSA requirements delayed until November 2024 | Hogan Lovells

The U.S. Food and Drug Administration (FDA) recently published a guidance for immediate implementation, Enhanced Drug Distribution Security Requirements Under Section 582(g)(1), that...

More Guidance Released from FDA for Drug Supply Chain Security Act Compliance | Quarles & Brady LLP - Vimarsana News

More Guidance Released from FDA for Drug Supply Chain Security Act Compliance | Quarles & Brady LLP

The Food and Drug Administration (“FDA”) released additional guidance documents on Wednesday, August 30th pertaining to the enhanced drug distribution security requirements under the...

Tracking Back to Track and Trace: Additional Guidance on Compliance with the DSCSA | Morgan Lewis - As Prescribed - Vimarsana News

Tracking Back to Track and Trace: Additional Guidance on Compliance with the DSCSA | Morgan Lewis - As Prescribed

Earlier in the summer, the FDA issued a quartet of guidance documents setting forth the Agency’s plan for implementing requirements under the Drug Supply Chain Security Act (DSCSA). The...

IHMA Chair Comments on Holography's Role in Supply Chain Security - Vimarsana News

IHMA Chair Comments on Holography's Role in Supply Chain Security

The chair of the International Hologram Manufacturers Association (IHMA) discusses how holography can be integrated with track and trace for security initiatives.

FDA issues new guidance to improve quality and security of prescription drugs in the U.S. supply chain - Vimarsana News

FDA issues new guidance to improve quality and security of prescription drugs in the U.S. supply chain

The following quote is attributed to Donald D. Ashley, J.D., Director of the Office of Compliance for FDA's Center for Drug Evaluation and Research